Skip to main content
Equibles

Squarepoint Ops LLC

Position in AVXL — Anavex Life Sciences Corp.

CIK 1642575 NEW YORK, NY
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$99,515
-$101,137 QoQ
Shares Held
38,423
-31.8% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 179 holders
Holding Since
Sep 2020
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Derivatives in AVXL

reported options exposure · as of Dec 31, 2022
CallValue
$0
CallShares
0
PutValue
$2,581,688
PutShares
278,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. AVXL ranks #227 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 198,567 $123,814,467
2 BBIO
BridgeBio Pharma, Inc.
 1,191,732 $88,760,199
3 ALNY
Alnylam Pharmaceuticals, Inc.
 233,999 $70,440,718
4 INSM
INSMED Inc
 616,464 $65,727,391
5 ARGX
Argenx SE
 58,400 $54,181,768
6 RYTM
Rhythm Pharmaceuticals, Inc.
 422,921 $46,956,918
7 APGE
Apogee Therapeutics, Inc.
 290,713 $38,586,336
8 AXSM
Axsome Therapeutics, Inc.
 154,605 $37,842,665

All Filings in AVXL

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $99,515 38,423
2025-12-31 $200,652 56,363
2025-06-30 $99,059 10,744
2024-12-31 $726,313 67,627
2024-09-30 $94,873 16,703
2024-06-30 $191,385 45,352
2023-12-31 $217,881 23,403
2023-09-30 $275,558 42,070
2023-06-30 $123,519 15,193
2022-12-31 $2,581,688 278,800
2022-12-31 $201,960 21,810
2022-09-30 $207,101 20,068
2021-12-31 $224,847 12,967
2021-09-30 $1,092,580 60,868
2021-06-30 $928,550 40,619
2021-03-31 $530,769 35,503
2020-09-30 $255,505 56,155